Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis

Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis

US Patent 5491152 · Granted Feb 13, 1996

Estimated economic value: $23,987,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted reverse pyrimidine Bmi-1 inhibitors2021
Substituted pyridine and pyrazine BMI-1 inhibitors2020
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2019
Substituted reverse pyrimidine Bmi-1 inhibitors2019
Substituted pyrimidine Bmi-1 inhibitors2019
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2018
Antibacterial agents: Nα-aroyl-N-aryl-phenylalaninamides2018
Carbazole carboxamide compounds2017
Antibacterial compounds and methods for use2017
1,3,4-oxadiazole benzoic acid compounds and their use for nonsense suppression a2017
Substituted tetrahydrocarbazole and carbazole carboxamide compounds2016
Compounds for nonsense suppression, and methods for their use2016